
Expert insights into prioritizing 340B as a system-wide program in your health system.
Explore the ways we’re fortifying our supply chain and helping our customers continue to receive the medications they need.
Date
October 28, 2024
Watch time: 1 minute
By: Stephen Stalker
At McKesson, we understand that maintaining a resilient supply chain is vital to serving providers and protecting patient access to life-saving medication. Learn more about our company’s actions, advocacy and partnerships to help address drug shortages in the video below.
Find more information on McKesson’s strategies for combating drug shortages here, including our comprehensive white paper – Drug Shortages: Root Causes and Recommendation.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
An exclusive introduction to our newest services and solutions designed to help forward-thinking health systems modernize their specialty and infusion strategies.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.
Integrated health system specialty pharmacies improve medication access, enhance treatment plan adherence, and support better outcomes.
Explore key trends and strategic recommendations from our experts to help you achieve more.
Review takeaways from the executive session sponsored by McKesson at Becker’s 12th Annual CEO + CFO Roundtable.